Cell-based_therapy_news.png

GID Bio Blog

Read Updates from GID Bio.

Cell-based_therapy_news.png

Device and point-of-care therapy intended to treat pain and function could soon help knee osteoarthritis patients

About 30 million U.S. adults suffer from osteoarthritis (OA). Many of these patients put up with pain ...

FDA-approved trial for cellular implant therapy could mean a major development in the treatment of pain associated with knee osteoarthritis

A randomized controlled Phase IIb clinical trial approved by the Food and Drug Administration (FDA) measuring safety and efficacy ...

GID BIO aims to close a healthcare gap with the launch of a cost-effective treatment for those suffering from osteoarthritis

Osteoarthritis (OA) is the most common form of arthritis due to the increasing number of ...

GID BIO’s results in randomized controlled Phase IIb clinical study support an evidence-based, data-driven approach to treat pain-management caused by osteoarthritis of the knee

While minimally invasive treatments transformed cardiology decades ago, advancements in orthopedic medicine are introducing potential ...

Interventional Orthopedics and Cell-based Medicine

A total knee replacement involves hours of surgery, a metal/polymer implant, and months of recovery. ...